The Shoreham Group is a boutique investor relations agency focusing on companies predominately in the areas of life sciences and technology. The firm specializes in connecting undervalued emerging growth companies with institutions, hedge funds, independent portfolio managers, buy-side and sell-side analysts, retail brokerage firms and accredited individual investors. Shoreham's primary services areas include investor relations, corporate and financial communications, financial advisory, and business development. Shoreham's focus is on the life science sector that encompasses biotechnology, specialty pharmaceuticals, diagnostics, tools and medical devices. The firm financial advisory services include merger and acquisition advisory, assisting in syndication of public and private financings, liaising with institutional investors and investment banking communities, and facilitating due diligence.